Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more

Bullboard (TSXV:RX)

View:
Comment by Torontojayon Jun 18, 2020 2:55pm

RE:RE:New Biosyent Interview with Bobby Kraft

It is my second largest holding. I think this stock is being ignored by everyone. Their future has never looked brighter but the stock has never appeared cheaper. Sales have slowed over the last year ...more  
Comment by Aarman4on Jun 18, 2020 2:02pm

RE:New Biosyent Interview with Bobby Kraft

I just watched it, very bullish... Highlights: - He is confident that next quarter will be profitable, their 40th consecutive profitable quarter. - 2 new products being released that he expects to ...more  
Post by Kadillacon Jun 17, 2020 2:07am

New Biosyent Interview with Bobby Kraft

Pretty bullish interview with CEO.   https://www.youtube.com/watch?v=QTNDAtFcgMo#action=share  
Post by retiredcfon Jun 10, 2020 11:37am

Assessment

The crew at 5iResearch were recently asked for their analysis of the recent results and they liked what they saw. Essentially it was a beat across the board. EPS nearly tripled and was 51% ahead of ...more  
Comment by theinvestor22on Jun 05, 2020 10:23am

RE:Reliq thoughts...

My apologies...wrong board...please ignore that post!
Post by theinvestor22on Jun 05, 2020 10:07am

Reliq thoughts...

I've been musing lately about Reliq's past, present and potential in light of things issued by the company/IR and commentary by several astute bulletin board posters and friends.   ...more  
Comment by theinvestor22on Jun 04, 2020 9:51pm

RE:RE:RE:RE:RE:RE:Q1 results

Having re-watched the presentation, I'm inclined to agree with you.  Here's the relevant bit:  "There is more news coming on the FeraMAX brand as we roll through, and not just ...more  
Comment by overnouton Jun 02, 2020 5:49pm

RE:RE:RE:RE:RE:Q1 results

Thanks for the feedback. I have been invested here for quite some time but not made any comments. I have appreciated your comments and those of Iscfa on Biosyent. The thing that tweeked my interest ...more  
Comment by theinvestor22on Jun 02, 2020 5:41pm

RE:RE:RE:RE:Q1 results

As I recall, on many of these quarterly presentations, Rene has refered in someway to there being something in the works.  He never gives specifics at least until a deal is made, and then he only ...more  
Comment by overnouton Jun 02, 2020 5:27pm

RE:RE:RE:RE:Q1 results

in regards to FeraMax? overnout
Comment by overnouton Jun 02, 2020 5:25pm

RE:RE:RE:Q1 results

Any ideas on what Rene is referring to at 13:35 of the Q1 presentation when he says, 'we've been working on a few things' over the past two years, which they will be reporting soon ...more  
Post by microcaphobbyon Jun 02, 2020 10:13am

q1 review

On their site you can listen to the conference call and review the slide deck. The company has been aggressively buying back shares. In this q alone (  since April 1)  they have bought back  ...more  
Comment by theinvestor22on May 31, 2020 4:46pm

RE:RE:Q1 results

Thanks for providing that update.  In the 4th paragraph, bloomburton said the Q1 gross margin was 30%.  That's a pretty weird number and kinda impossible since the pre-tax net margin was ...more  
Comment by lscfaon May 30, 2020 12:23pm

RE:Q1 results

Bloom Burton dropped the target price to $6.00 from $9.00 in March. Maintaining it at $6.00 now. https://www.bloomburton.com/research/RX20200529.pdf       
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities